Research has shown that the Parkinson’s drug, rasagiline, could be a viable therapeutic option for people with Alzheimer’s disease. Learn about the new effort to
VIDEO + ARTICLE CERE-110 is a big step forward for Alzheimer’s clinical trials. It induces brain cells to make their own nerve-growth-factor, so they can
VIDEO & ARTICLE: See how doctors implant a deep-brain-stimulation device in “The Advance Study”. Learn how its electrodes stimulate a part of the brain called
Alzheimer’s is the most common type of dementia, but there are many others. Should Gulf War Illness, which effects over 250,000 troops deployed in the
Top experts at world-renowned Johns Hopkins Medicine did a systematic review of existing statin studies. Unlike the FDA, they found no connection between short-term statin
Pramlintide (known by the brand name Symlin®, an FDA-approved diabetic drug) reduces Alzheimer’s amyloid-beta peptides in the lab. Learn how it improves learning and memory.
VIDEO+ARTICLE A cutting-edge lab in Cambridge is using human brain cells made in the lab to test experimental Alzheimer’s drugs. See how the use of
VIDEO+ARTICLE Cognoptix announced strong results in a clinical trial of its SAPPHIRE II eye test. It successfully identified Alzheimer’s via the human eye’s beta-amyloid signature.
VIDEO+ARTICLE Simple eye tests have the potential to transform the way Alzheimer’s is detected and managed. Find out how two quick, low-cost Alzheimer’s eye tests
Turbocharging the popular Alzheimer’s drug called Namenda with nitroglycerin achieved a better level of treatment in the lab. Learn how the new formulation, called NitroMemantine,
The Founder and CEO of The Brainwell Institute shares the deep understanding of cognitive function that’s needed for a good diagnosis of dementia. Learn what you need to know, in plain English.
STUDY OF 200,000 SWEDE SKIERS: 50% less likely to develop vascular dementia, half as likely to be depressed, and if Parkinson’s strike, it’s very delayed – despite pathological changes in the brain. Learn more.
ARTICLE + VIDEO INFOMMERCIAL: Namazaric for dementia comes in a convenient, extended-release capsule. It conveniently combines today’s 2 most popular drugs for Alzheimer’s. Learn about easy-to-manage Namazaric.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
